102 filings
8-K
NTLA
Intellia Therapeutics Inc
9 May 24
Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
7:40am
8-K
NTLA
Intellia Therapeutics Inc
15 Apr 24
Departure of Directors or Certain Officers
4:21pm
8-K
NTLA
Intellia Therapeutics Inc
22 Mar 24
Termination of a Material Definitive Agreement
9:26am
8-K
NTLA
Intellia Therapeutics Inc
23 Feb 24
Amendment No. 1 to the Open Market Sale Agreementsm
5:17pm
8-K
NTLA
Intellia Therapeutics Inc
22 Feb 24
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
7:45am
8-K
elr 0qtal
1 Feb 24
Regulation FD Disclosure
4:05pm
8-K
fk1u2w
4 Jan 24
Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones
4:07pm
8-K
pqjsxh0970bh2miro
6 Dec 23
Departure of Directors or Certain Officers
7:00am
8-K
ejtig28
9 Nov 23
Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
7:45am
8-K
x0kz9o qk1
2 Nov 23
Intellia Presents New Interim Data from the Ongoing Phase 1 Study of NTLA-2001 at the 4th International ATTR Amyloidosis Meeting
7:11am
8-K
o753xfwb
18 Oct 23
Intellia Therapeutics Announces FDA Clearance of
7:30am
8-K
7r7o09jmeqaj34
3 Oct 23
Regeneron and Intellia Announce Expanded Research Collaboration
7:19am
8-K
09vovon
3 Aug 23
Intellia Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
7:45am
8-K
5xels9nx
16 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:13pm
8-K
ymwmu
12 Jun 23
Intellia Therapeutics Announces New Positive Clinical Data from Phase 1 Study of
7:00am
8-K
53rgj2
5 Jun 23
Departure of Directors or Certain Officers
4:52pm
8-K
b8b gt1mx
4 May 23
Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
7:41am
8-K
wqeo83cs6l
17 Apr 23
Intellia Therapeutics Names Bill Chase to its Board of Directors
4:59pm
8-K
uzgmrmup 1myno1
24 Mar 23
Departure of Directors or Certain Officers
7:00am
8-K
fywb 5wgcd24h
2 Mar 23
Intellia Therapeutics Announces FDA Clearance of Investigational New Drug
7:30am